A nicotinic acetylcholine receptor (AChR) on bovine adrenal chromaffin cells in culture has previously been identified using the cu-neurotoxin n-Bgt and the monoclonal antibody mAb 35. Here, we report that the cells have 2 classes of high-affinity binding sites for 3H-nicotine, one being associated with the AChR and the other being associated with the ar-bungarotoxin binding component that is distinct from the AChR. Scatchard analysis of 3H-nicotine binding to the AChR site yields a KD of 20 + 3 nM and a B,,,,, of 104 f 12 fmol/mg protein.
Nicotinic antagonists block 3H-nicotine binding to the AChR site with the same rank order of potency and affinity with which they block nicotine-induced catecholamine release from the cells. About 80% of the AChRs are on the cell surface, as judged by the distribution of both 3H-nicotine binding and 1251-mAb 35 binding to the receptor, and the ratio of nicotine/mAb 35 binding to the AChR on the cell surface is approximately 1 :l . Chronic treatment of the cells with mAb 35 results in receptor modulation such that all of AChR-related nicotine binding is lost from the cell surface, and all of the functional response to nicotine is lost as well. The results confirm that 3H-nicotine binding is associated with AChRs on the cells.
The 3H-nicotine binding observed to the AChR represents binding to a desensitized form of the receptor having increased affinity for agonists and unchanged affinity for antagonists.
This conclusion derives from the following observations.
The K,S for agonist competition of 3H-nicotine binding indicate agonist affinities several orders of magnitude greater than do the &,S measured for receptor activation. Exposing cultures to low concentrations of nicotine and substance P causes receptor desensitization, and the concentration dependence of the nicotine-induced desensitization displays an EC,, of 20 nM, in good agreement with the K, obtained from equilibrium binding studies with 3H-nicotine. In addition, the rate of 3H-nicotine binding is increased both by substance P, which enhances the rate of agonist-induced desensitization on adrenal chromaffin cells, and by preincubation with nicotine. The increased rate of association, together with the dissociation rate, yields a kinetically derived K, of 19 nu, again in good agreement with the K,, ob-tained from equilibrium binding studies. These results demonstrate that the bovine adrenal chromaffin AChR is similar to AChRs from muscle and electric organ in undergoing an agonist-induced conversion to a desensitized state having increased affinity for agonists.
Nicotinic acetylcholine receptors (AChRs) trigger catecholamine release from bovine adrenal chromaffin cells when activated by synaptic transmission from the splanchnic nerve. The AChRs bind nicotinic ligands and display ion selectivities and single-channel properties generally similar to those previously described for AChRs from muscle, electric organ, and neurons (Brandt et al., 1976; Fenwick et al., 1982; Kidokoro et al., 1982) . Unlike AChRs from muscle and electric organ, however, the receptors on bovine adrenal chromaffin cells are not blocked by neurono-bungarotoxin (n-Bgt) (Trifaro and Lee, 1980; Kilpatrick et al., 198 1; Higgins and Berg, 1987a) ; they are blocked instead by bungarotoxin 3.1 (Bgt 3.1) (Higgins and Berg, 1987a) , previously referred to as bungarotoxin 3.1, toxin F or kappabungarotoxin (Loring and Zigmond, 1988) . In this respect the receptors are similar to those on chick ciliary ganglion neurons (Ravdin and Berg, 1979) and rat sympathetic neurons (Sah et al., 1987) . A resemblance between adrenal chromaffin AChRs and neuronal AChRs is to be expected since adrenal chromaffin cells share many properties with sympathetic neurons: both cell types derive from the neural crest, generate action potentials, synthesize and release catecholamines, and receive synaptic input from preganglionic neurons in the spinal cord. Relatively little is known about adrenal chromaffin and vertebrate neuronal AChRs because until recently suitable probes were not available for studying the receptors. Two probes have now been demonstrated to distinguish the bovine adrenal chromaffin AChR. The first of these is a monoclonal antibody, mAb 35, to the "main immunogenic region" of muscle and electric organ AChR (Y subunit. mAb 35 cross-reacts with the AChR of chick ciliary ganglion neurons (Jacob et al., 1984; Smith et al., 1985 Smith et al., , 1986 Halvorsen and Berg, 1987) and the AChR ofbovine adrenal chromaffin cells (Higgins and Berg, 1987a) . The second probe is n-Bgt, which blocks most of the nicotine-induced catecholamine release of bovine adrenal chromaffin cells and also modulates, or down-regulates, the number of AChRs on the cells available to bind mAb 35 (Higgins and Berg, 1987a) . oc-Bgt binds to a membrane component on bovine adrenal chromaffin cells, but the component appears to be distinct from the functional AChR (Higgins and Berg, 1987a, and unpublished observations) , as has been shown for the cy-Bgt binding component and functional AChRs on chick ciliary ganglion neurons (Jacob and Berg, 1983; Smith et al., 1983 Smith et al., , 1985 Jacob et al., 1984; Halvorsen and Berg, 1986 ) and the rat pheochromocy-toma cell line PC12 (Patrick and Stallcup, 1977; Mitsuka and Hatanaka, 1983) . The function of the cu-Bgt binding component on these cells is unknown.
Labeled cholinergic ligands have been used to examine the regional distribution of AChRs in brain (Marks and Collins, 1982; Schwartz et al., 1982; Clarke et al., 1984 Clarke et al., , 1985a and to characterize putative neuronal AChRs from brain tissue (Romano and Goldstein, 1980; Abood et al., 1983; Lippiello and Fernandes, 1986; Marks et al., 1986; studies reveal agonist affinities that generally are several orders 1986a, b, 1987a) . A substantial discrepancy exists, however, between the measured affinities for labeled agonists binding to putative neuronal AChRs and the affinities inferred from physiological studies of AChR activation on neurons. The binding buffer at 37°C. The filter and rinse procedure was completed in a total of 15 sec. After the filters were allowed to dry, radioactivity retained Data are presented as the mean * SEM of triplicate determinations and on the filters was determined by liquid scintillation counting with a Beckman LS-1OOC counter using Aquasol-or Liquiscint as solvent and fluor. Nonspecific binding was determined in the presence of 1 mM carbamylcholine (carbachol) inless otherwise indicated and has been subtracted.
The efficiency of receptor recovery after scraping and retention on the filters in the assay was determined in the following manner. Sister cultures labeled with 1251-mAb 35 (see below) were either scraped in 0.2 ml of 0.6 N NaOH for measurina radioactivity in a Tracer analytic 1191 gamma counter directly or were scraped in rinse buffer, hornogenized, centrifuged, resuspended, rapidly filtered as done for )H-nicotine binding assays and counted for radioactivity retained by the filters, A comparison of the 2 procedures indicated a mean value of 65 f 6% (tSEM, n=4) for the overall efficiency of recovery in the filter assay.
of magnitude higher than those suggested by the physiological responses ofthe receptors (Halvorsen and Berg, 1986; Margiotta et al., 1987) . In contrast, the affinities of cholinergic antagonists measured in binding assays agree well with those obtained from physiological assays (Clarke et al., 1985b) . A possible explanation is suggested by the binding properties of muscle and electric organ AChR whose agonists induce a slow conversion of the receptor to a desensitized state with dramatically increased affinity for agonists and little if any change in affinity for antagoni sts (Rang-and Ritter, 1969, 197ba, b; Sine and Taylor, 1979; Weiland and Taylor, 1979; Heidmann et al., 1983) .
A similar phenomenon has been suggested for neuronal AChRs to account for the discrepancy in agonist affinities (Halvorsen and Berg, 1986; Whiting and Lindstrom, 1986b; have been corrected for assay efficiency.
Nicotine binding to intact cells was measured by replacing the media with media containing 20 nM 'H-nicotine and 1O-6 M ol-Bgt, and incubating for 70 min at 37°C. Cultures were rinsed 4 times with 1 ml of rinse buffer, scraped in 0.1 ml 0.6 N NaOH, and assayed for radioactivity using liquid scintillation. Nonspecific binding was measured in the presence of 1 mM carbachol and has been subtracted.
Cutecho/umine release. Catecholamine release was determined as previously described (Higgins and Berg, 1987a) . Briefly, cultures were preloaded with 'H-norepinephrine ('H-NE) for 2 hr at 37°C and then rinsed for 1 hr. Catecholamine release induced either by agonist at the indicated concentration or by 54 mM K+ was measured by determining the radioactivity present in aliquots of the release media and of cell lysates obtained by scraping cultures in 0.6 N NaOH. 'H-NE release is expressed as a percentage of the total radioactivity present in the cells prior to induced release. Sinale data points represent the mean * SEM of triolicate determinations. Basal release, measured in the absence of secretaal., 1987) . No direct demonstration of a desensitized state with increased affinity for agonists has been provided for neuronal AChRs.
We show here that 3H-nicotine binds with high affinity to a desensitized form of the AChR on bovine adrenal chromaffin cells. The receptor is the same as that previously identified by mAb 35 binding and can be modulated by exposure to mAb 35. Desensitization of the receptor is accompanied by an increase in agonist affinity with no apparent change in antagonist affinity. Some of these results have been described in a preliminary account (Higgins and Berg, 1987b) .
Materials and Methods
CeN cultures. Bovine chromaffin cells were dissociated from adrenal medullae, purified on Percoll gradients, and maintained in culture as previously described (Higgins and Berg, 1987a) . Cultures were prepared with 5 x lo5 cells per 16 mm well (1 culture equivalent) or 1.5 x lo6 cells/35 mm dish (3 culture equivalents) in culture medium consisting of Dulbecco's Modified Essential Medium (DMEM) containing 10% (vol/vol) fetal bovine serum, 50 U/ml penicillin Cl, and 50 &ml streptomycin. Cultures were maintained at 35°C in 5% CO,/95% air and received fresh medium every 2 d. Cytosine arabinoside was included in the medium at a final concentration of 10-S M after the first day. Cultures were taken for experiments 3-8 d after plating.
3H-nicotine bindina. To determine 'H-nicotine binding to membrane fragments, cultures were scraped in 5 mM HEPES, pH 7.4, containing 137 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO,, 0.9 mM Na,PO,, 0.4 mM KH,PO,. 1.8 mM CaCl,. 5.6 mM alucose, and 2 me/ml BSA (rinse buffer), homogenized in a glasstissue homogenizer, and-centrifuged for 10 min in an Eppendorf microfuge at 15,600 x g. The pellet was resuspended in rinse buffer. Nicotine binding to the membrane fragments was carried out by incubating 3 culture equivalents of homogenate in 0.15 ml rinse buffer containing 20 nM 'H-nicotine and 1 I.~M cu-Bgt, unless otherwise indicated, for 70 min at room temperature (standard conditions). At the end of the reaction period, 0.05 ml aliquots of the reaction mixture were diluted to 5 ml, rapidly filtered over Whatman GF/B glass fiber filters that had been presoaked overnight in 0.0 1 O/o polylysine to reduce nicotine binding to the filters, and washed 3 times with 5 ml of rinse gogue, has been subtracted. mAb 35 binding. 1251-mAb 35 bindina to intact cells was measured as described by H&gins and Berg (1987a) : Cultures were incubated with 5 nM l*%rnAb 35 for 1 hr at 37°C washed, scraped in 0.6 N NaOH, and analyzed for radioactivity. Nonspecific binding was determined in the presence of 5 x lo-' M unlabeled mAb 35. Antibody binding to detergent extracts was determined using small DEAE cellulose columns as described by Stollberg and Berg (1987) . Reaction mixtures contained 3 culture equivalents of extract and 2 nM '251-mAb 35, and bound lzsImAb 35 was determined in triplicate. Nonspecific binding was determined in the presence ofexcess unlabeled mAb 35. Data points represent the mean ? SEM of such triplicates and have been corrected for the efficiency of the assay (70 ?Z 6%, n = 5), determined as described by Stollberg and Berg (1987) . a-Bgt binding. cu-Bgt binding to intact cultures was determined as described by Smith et al. (1983) . Briefly, culture media were replaced with media containing 10 nM lz51 a-Bgt. After incubating for 1 hr at 37°C the cultures were washed, scraped in 0.6 N NaOH, and analyzed for radioactivity. Nonspecific binding was determined in the presence of 10m6 M unlabeled a-Bgt.
Protein determination. Protein determinations were carried out by rinsing cultures 4 times with 1 ml aliquots of rinse solution lacking BSA, scraping the cells in 0.5 ml 0.6 N NaOH, diluting with an additional 0.5 ml of 0.4 N NaOH, and assaying for protein by the method of Lowry et al. (195 1) . BSA was used as a standard, and blanks were determined by assaying culture wells maintained with medium but lacking cells.
Materials. Bovine adrenal glands were obtained at Talone Packing Co., Escondido, CA. 'H-@)-nicotine (specific activity, 60-80 Ci/mmol) was purchased from New England Nuclear, Liquiscint from National Diagnostics, and cholinergic ligands from Sigma with the exception of trimethaphan camsylate, which was the generous gift of Dr. W. E. Scott from Hoffman LaRoche, New Jersey. The hybridoma cell line secreting mAb 35 was generously provided by Jon Lindstrom of the Salk Institute. mAb 35 was purified and radioiodinated to specific activities of 2-3 x lOI cpm/mol as previously described (Smith et al., 1985) . n-Bgt and oc-Bgt were purified from Bungarus multicinctus venom (Miami Serpentarium) as previously described (Ravdin et al., 198 1) . '%or-Bgt was prepared and isolated with initial specific activities of 250-300 Ci/mmol as previously described (Smith et al., 1985) . Culture media components and other reagents were obtained as previously described (Higgins and Berg, 1987a (Wilson and Kirshner, 1977; Trifaro and Lee, 1980; Quick et al., 1986; Higgins and Berg, 1987a) . As shown in Figure 1 , 3H-nicotine binding to adrenal chromaffin culture membranes can be divided pharmacologically into 2 classes. One class ofbinding sites, representing about 50% of the specific binding obtained with 20 nM 3H-nicotine, is blocked by lo-' M cY-Bgt, while the remainder is not inhibited even by 1O-5 M cu-Bgt. Since cr-Bgt does not prevent nicotine from activating AChRs on the cells (Trifaro and Lee, 1980; Higgins and Berg, 1987a) , the cY-Bgtresistant 'H-nicotine sites were chosen for additional study as candidates for functional AChRs. In all subsequent experiments, 1O-6 M cu-Bgt was routinely included in the binding reaction to block 3H-nicotine binding to the Lu-Bgt binding component. This strategy facilitated characterization of 3H-nicotine binding to the AChR described below. Nicotine binding to a putative AChR Specific binding of 3H-nicotine to adrenal chromaffin membranes in the presence of 1O-6 M Lu-Bgt reached equilibrium within 60 min at 22°C ( Fig. 2A) . Dissociation of the ligand occurred with a half-time under 2 min ( Fig. 2B ). Both association and dissociation curves can be described by single-exponential functions (insets, Figs. 2, A, B), as would be predicted for a single class of nicotine binding sites. Kinetic analysis of 4 such experiments yielded a value for the dissociation rate constant (k-J of 0.343 + 0.040 min-I mol-I (mean + SEM). The association rate constant (k,) was calculated to be 1.1 + 0.3 x lo6 min-' according to the method of Fields et al. (1978) . The equilibrium dissociation constant (K,J derived from k, and k-, is 391 nM, 20-fold greater than the K, derived from Scatchard analysis (see below). This discrepancy indicates that the observed 3H-nicotine binding cannot be described as a simple, reversible bimolecular reaction. Instead, the binding is complicated by an apparently rate-limiting, agonist-induced conversion of receptor sites to a form having high affinity for nicotine (see below). In subsequent experiments, binding reactions were normally carried out for 70 min and were terminated by rapid filtration and washing in a total of 15 sec. Near saturation of binding was achieved with 45 nM 3H-nicotine (Fig. 3) . Scatchard analysis revealed a single class of high-affinity binding sites with an apparent dissociation constant, KD, of 20 & 2 nM (mean -t SEM, n=4). This value falls within the wide range of affinities (2-30 nM) reported for highaffinity nicotine binding to rat and chicken brain membrane components (Roman0 and Goldstein, 1980; Clarke et al., 1984; Lippiello and Fernandes, 1986; Marks et al., 1986; Whiting and Lindstrom, 1986b 6.6 x 10-7 3.3 x 10-1 1.1 3.4 x 10-S 1.7 x 10-a 0.93 7.6 x 1O-5 3.8 x 1O-5 1.1 2.1 x 10-e 1.0 x 10-C 1.0 3.6 x lo-' 1.8 x lo-' 0.99 6.6 x 10-g 3.3 x 10-g 1.0
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Inhibitory binding constants (K,) were calculated as described by Chengand Prusoff (I 973) using data from the competition binding studies with 'H-nicotine described in Figure 4 . In the case ofACh, 10m5 M eserine was included in the binding reactions to prevent hydrolysis of the agonist. Hill coefficients (n,,) were determined by transforming the data to Hill plots. Lines were fit by least-squares analysis with correlation coefficients ~0.96.
terial for the range tested (O-O.5 mg protein/assay, data not shown).
Pharmacology of nicotine binding
The pharmacology of the high-affinity nicotine binding sites was examined in competition binding studies using 20 nM 3H-nicotine and a variety of cholinergic ligands over a range of concentrations. Again 10m6 M cY-Bgt was included throughout to prevent the 3H-nicotine from binding to the cz-Bgt binding component. In each case the competing ligand was added 10 min prior to the 3H-nicotine, and binding was then carried out for the standard 70 min at 22°C followed by 15 set of filtration and washing. All of the specific )H-nicotine binding, defined by inhibition with 1 mM carbachol, was blocked as well by a number of nicotinic agonists ( Fig. 4A ) and antagonists (Fig. 4B) . The inhibition constants (K,) for various cholinergic ligands, calculated from data such as those shown in Figure 4 , are listed in Table 1 . In all cases the Hill coefficients (n,) were near unity (Table 1) . n-Bgt blocks nicotine-induced catecholamine release from bovine adrenal chromaffin cells in culture (Higgins and Berg, 1987a) and so was also examined for blockade of 3H-nicotine binding to membrane fragments prepared from the cultures. The toxin was preincubated with the membranes for 40 min at 22°C to allow binding, and then 3H-nicotine was added to initiate the standard competition reaction. n-Bgt at 10e5 M blocked about three-quarters of the binding (Fig. 5) ; it was not practical to test higher concentrations. The breadth of the concentration dependence suggests heterogeneity in the 'H-nicotine sites with respect to n-Bgt binding.
Pharmacology of the functional AChR
The pharmacology of functional nicotinic receptors on bovine adrenal chromaffin cells was examined for comparison with the pharmacology of the 3H-nicotine binding sites described above.
In these experiments, the cells were first loaded with )H-NE, washed, and then tested for release of radioactivity induced by a cholinergic ligand within a 3 min test period. Previous studies demonstrated that the assay was specific for AChR-mediated catecholamine release and that it was dependent on extracellular Caz+ as expected for synaptic release (Trifaro and Lee, 1980; Kilpatrick et al., 198 1; Higgins and Berg, 1987a) . The maximal release elicited in the present experiments with each of the 3 agonists tested, namely, ACh, carbachol, and nicotine, was about 14% of the radioactivity associated with the cultures at the beginning of the test period (Fig. 6) . Basal release, measured in the absence of secretagogue, has been subtracted. The submaximal levels of release observed with high concentrations of agonist ( Fig. 6 ) suggest that AChRs on the cells desensitize (see below). Bovine adrenal chromaffin cells elaborate functional muscarinic as well as nicotinic receptors. Only nicotinic receptors, however, are thought to mediate catecholamine release from these cells (for review, see Livett, 1984) . The 2 muscarinic agonists tested, oxotremorine and pilocarpine, did not elicit jH-NE release at 1 O-5 M (data not shown). Nevertheless, to exclude the possibility that catecholamine release in the present experiments with ACh and carbachol included a contribution from muscarinic receptors, the muscarinic antagonist atropine was included at 10m6 M in the release assay when testing these 2 agonists. Atropine at 10m6 M completely blocks activation of muscarinic receptors on bovine adrenal chromaffin cells by ACh (Fischer et al., 1981) . In addition, eserine was included at 1O-5 M in the release assay when ACh was tested to prevent hydrolysis Concentrations required to reach half-maximal activation (EC,,app) and apparent Hill coefficients (n,,app) were determined by transforming the data in Figure 6 to Hill plots. True EC,,+ and n,,s cannot be determined due to desensitization of the response, especially at higher doses of agonist. r, correlation coefficient for least-squares analyses of data for Hill plots; n, number of separate experiments. of the agonist. No release was elicited by decamethonium (data not shown), a partial agonist at the muscle nicotinic AChR (Sine and Taylor, 1979) . The concentrations eliciting half-maximal release (EC,,apps) and the corresponding apparent Hill coefficients were calculated from data such as those shown in Figure  6 and are listed in Table 2 . True EC,,s and nHs could not be calculated since desensitization prevented accurate measurement of maximal responses. However, electrophysiological measurements have indicated EC,, values of l-l.5 x 10m5 M for ACh on rat adrenal chromaffin cells (Kidokoro and Ritchie, 1980; Kidokoro et al., 1982) which agree well with the value of 1.5 x 1 O-5 M calculated here and suggest that the EC,,apps may be good estimates of the true EC,+. The ability of cholinergic antagonists to block the catecholamine release elicited by nicotine was investigated by assaying for 3H-NE release in the presence of 1 O-6 M nicotine and a variety of competing ligands over a range of concentrations (Fig. 7) . Cultures were incubated with the antagonists for 60 min prior to the 3 min test period to allow binding to reach equilibrium. a-Bgt did not significantly block nicotine-induced catecholamine release over the concentration range tested, as expected since the oc-Bgt binding component on the cells is thought to be distinct from the functional AChR (Trifaro and Lee, 1980; Kilpatrick et al., 1981; Higgins and Berg, 1987a) . The apparent inhibition constants and Hill coefficients for each of the antagonists were calculated from data such as those shown in Figure  7 and are listed in Table 3 .
Both the rank order potency and the K, values for antagonists in the binding assay are in good agreement with those obtained for the antagonists in the functional assay. The results are consistent with the high-affinity binding site detected by 'H-nicotine as being the same site at which nicotine elicits AChR-mediated catecholamine release from the cells. In contrast, there is a large discrepancy in affinities of agonists detected by the binding assay compared with those obtained from the functional release assay. Values derived from the former are several orders of magnitude higher than those derived from the latter. A similar phenomenon has been described for muscle Ritter, 1969, 1970a, b; Sine and Taylor, 1979) and electric organ AChRs (Weiland and Taylor, 1979; Heidmann et al., 1983) , where cholinergic agonists have been shown to induce a slow transition of the AChR to a desensitized state with much increased affinity for agonists. In general, antagonists seem neither to induce the conversion nor to differentiate between the receptor states with respect to binding affinity. It is known that adrenal chromaffin AChRs dcscnsitizc (Clapham and Nehcr, 1984) . The long incubation times used to achieve equilibrium in the 3H-nicotine binding experiments may be necessary to allow desensitization of the AChR so that a high-affinity nicotine binding state will result that is detectable in the binding assay. To test this possibility, experiments were carried out to identify desensitizing conditions for the adrenal chromaffin AChR and to examine the effects of these conditions on 3H-nicotine binding.
Desensitization of the AChR response
The effects of a 1 hr pre-exposure to agonist were tested on AChR desensitization since binding experiments were usually carried out for 1 hr. Cells were first loaded with 3H-NE, incubated with low concentrations of nicotine for 60 min at 37"C, and then tested for 3H-NE release in response to various concentrations of nicotine during a 3 min test period. (The nicotine concentrations chosen for the pre-exposure were inadequate to induce measurable )H-NE release.) To increase the rate of possible receptor desensitization by nicotine, 10m5 M substance P was included in the initial 1 hr incubation. Previous electro- Concentrations required to inhibit half of the nicotine-stimulated 'H-NE release (IC,,) and Hill coefficients (n,,) were calculated from indirect Hill plots using the data shown in Figure 7 . K,app was calculated as described by Cheng and Prusoff (1973) using the EC,,app for nicotine shown in Table 2 . Correlation coefficients of least-squares fit of data in modified Hill plots were ~0.98.
physiological (Clapham and Neher, 1984) and catecholamine release studies (Mizobe et al., 1979; Role et al., 1981; Livett and Boska, 1984) have demonstrated that substance P enhances the rate but not the extent of AChR desensitization on adrenal chromaffin cells. The pretreatment with nicotine and substance P dramatically reduced the maximal response of the cells without significantly changing the EC,,app of the response for nicotine (Fig. 8) , as expected for treatments promoting receptor desensitization. Preincubation with substance P alone had no effect on nicotine-induced catecholamine release. The effects of nicotine and substance P were specific in that the treatment had no effect on basal release or on release induced by 54 mM K+ (data not shown). The effects were reversible since a 1 hr wash restored nicotine-induced )H-NE release to control levels (data not shown).
The concentration dependence of receptor desensitization by nicotine was determined by incubating cultures with a range of nicotine concentrations for 1 hr in the presence of 1O-5 M substance P and then assaying the release of 3H-NE induced by 1 Oe6 M nicotine in the standard 3 min test period (Fig. 9) . Using Eadie-Hofstee analysis, a value of 20.2 ? 4.6 nM (mean -t SEM; n = 6) was calculated for the EC,, for nicotine desensitizing the functional response under these conditions. (Receptor desensitization was also obtained in several experiments in which substance P was omitted from the preincubation (data not shown).) The EC,, value is in excellent agreement with the KD for 3H-nicotine binding obtained by Scatchard analysis, supporting the hypothesis that the high-affinity site detected with 3H-nicotine and the site at which nicotine desensitizes the functional cholinergic response are the same.
Eflects of desensitizing conditions on jH-nicotine binding
The hypothesis that the high-affinity binding site detected by 3H-nicotine represents the desensitized AChR on adrenal chromaffin cells was tested further by examining the effects of desensitizing conditions on the rate of association of 3H-nicotine with its binding site. Inclusion of 10e5 M substance P in the reaction increased the rate of 3H-nicotine binding but had no effect on the equilibrium levels of binding (Fig. 10) . These results are consistent with substance P increasing the rate, but not the extent, of conversion for the nicotine binding site to a highaffinity state, as was found for the effects of substance P on AChR desensitization. The association rate of 3H-nicotine was also measured after a 70 min exposure of membrane fragments to 20 nM unlabeled nicotine in the absence of substance P (Fig.  10) . Equilibrium binding of 3H-nicotine was reached by 6 min rather than by 60 min as required in the absence of prior exposure of the membranes to agonist. An association rate constant was calculated from 4 experiments according to the method of Fields et al. (1978) and yielded a value of 1.8 & 0.2 x 10' min-lmol-' (mean + SEM). When this association rate constant is used together with the dissociation rate constant to calculate the KD for 3H-nicotine binding, a value of 19 nM is obtained. This is in good agreement with the KD obtained from Scatchard analysis for 3H-nicotine binding. The results indicate that low concentrations of nicotine can induce a receptor state that is functionally desensitized. Moreover, the same conditions that produce desensitization also induce the high-affinity binding state for nicotine and strongly suggest that the )H-nicotine binding observed to adrenal chromaffin cell membranes represents binding to a desensitized form of the functional AChR.
Surface and internal pools of receptor The 3H-nicotine binding experiments described above were carried out with membrane fragments prepared from adrenal chromaffin cultures because the system presented a favorable signal to noise ratio for examining 3H-nicotine binding. Binding to membrane fragments would be expected to include contributions from AChRs both in the plasma membrane and in internal membranes associated with intracellular organelles. There is precedence for large intracellular pools of AChRs both in neurons (Jacob et al., 1986; Stollberg and Berg, 1987) and in muscle (Devreotes et al., 1978; Merlie and Lindstrom, 1983; Pestronk, 1985) . Accordingly, 3H-nicotine binding experiments were also carried out with intact cells in adrenal chromaffin cultures to determine the proportion of high-affinity nicotine binding sites present on the surface of the cells. Background 3H-nicotine binding was substantial in the cultures, but it was possible to estimate the proportion of surface sites as constituting approximately 80% of the total specific sites associated with the cells (Table  4 ). Scatchard analysis of 'H-nicotine binding to intact cells indicated a single population of sites (in the presence of 1O-6 M Bgt) with a K, of about 20 nM (data not shown), as observed for binding to membrane fragments described above. mAb 35 has previously been shown to cross-react with AChRs on adrenal chromaffin cells (Higgins and Berg, 1987a) . The total number of specific mAb 35 binding sites associated with membrane fragments was measured and compared with the number (Table 4 ). The ratio for internal sites could not be meaningfully calculated from the data because of the relatively large SEMs associated with the values.
mAb 35 modulation of nicotine binding sites Extended exposure of adrenal chromaffin cells to mAb 35 has previously been shown to eliminate nicotine-induced catecholamine release, suggesting that the antibody can down-regulate the receptor through antigenic modulation (Higgins and Berg, 1987a) . mAb 35 does not compete directly with 3H-nicotine for binding (data not shown), a result consistent with the failure of mAb 35 to block AChR function Smith et al., 1986; Higgins and Berg, 1987a) . It is known that antibodies to the "main immunogenic region" of muscle and electric organ AChR (Y subunit can induce the clustering, internalization, and degradation of muscle AChRs (Heinemann et al., 1977; Merlie et al., 1979) . The possibility of antigenic modulation by mAb 35 to remove AChRs from the cell surface was tested here by measuring the number of 'H-nicotine binding sites remaining on the cells and present in membrane fragments from cultures after incubation with mAb 35 for 24 hr. The treatment completely removed the surface sites and reduced the number of sites in membrane fragments by about 80% (Fig. 11) . The remaining sites in the membrane fragments apparently represent the preexisting intracellular pool of AChRs. The numbers of total and surface oc-Bgt binding sites were unaffected by the antibody (Fig. 11) . 8.6 k 0.4 (6) 1.6 + 0.8 3H-nicotine 11.4 k 1.5 (12) 8.9 zk 1.6(9) 2.5 f 1.9
Ratio mAb 35/nit 0.9
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Total 'z51-mAb 35 binding sites were measured for extracts prepared from adrenal chromaffin cultures using small DEAE cellulose columns. Total 'H-nicotine sites were assaved usine rauid filtration under standard conditions. In both cases, values were cokected fo; assay efficiencies (70 and 65%, respectively), determined as described in Materials and Methods. Surface sites were assayed on intact cells, and the number of internal sites was calculated by subtracting the number of surface sites from the number of total sites. In all cases, values have been corrected for fractional occupancy (9) 
Discussion
The major findings reported here are that (1) the AChRs responsible for mediating catecholamine release from bovine adrenal chromaffin cells can be detected by high-affinity 3H-nicotine binding, and (2) the rate-limiting step in obtaining the observed binding is the formation of a desensitized receptor state having increased affinity for agonists. The first conclusion derives from the following. Scatchard analysis indicates a single class of high-affinity 3H-nicotine binding sites on the cells (when 1O-6 M cu-Bgt is used to prevent nicotine binding to cu-Bgt binding sites). Binding to this site is inhibited by classical cholinergic antagonists with the same affinities that the antagonists inhibit AChR function, and the binding of the antagonists display Hill coefficients close to 1. The stoichiometry of mAb 35 and 'Hnicotine binding on the cells is approximately 1, and mAb 35 has previously been shown to be a specific probe for AChRs on the cells (Higgins and Berg, 1987a) . Antigenic modulation of AChRs on the cells by mAb 35 results in the specific and complete loss of AChR function and high-affinity 3H-nicotine binding from the cells in a coordinate way. The second conclusion derives from the observation that agonist-induced desensitization of the receptor accelerates the subsequent rate of 3H-nicotine binding to the cells. The rates of association and dissociation under these conditions yield a kinetically derived KD for nicotine binding that is equivalent in value to that obtained from equilibrium binding studies. Moreover, the apparent K, obtained for receptor desensitization by nicotine is equivalent to the KD obtained for 3H-nicotine from equilibrium binding studies. Agonist-induced conversion of the receptor to a desensitized form having increased agonist affinity accounts for the differences between the apparent EC,,'s obtained for receptor activation by agonists in the short catecholamine release assay and the K,'s measured for inhibition of 'H-nicotine binding by the agonists in the longer binding assay.
These findings are consistent with the model proposed by Katz and Thesleff (1957) for desensitization of muscle AChR in which agonist association and dissociation are rapid and agonist-induced conversion of the receptor to the desensitized state is slow. The higher affinity of agonists for the desensitized state drives the binding reaction. Antagonists, with the excep-tion of metaphilic antagonists, have the same affinity for the 2 onic chick brain and ciliary ganglia (Jacob forms and therefore do not induce the desensitized form. Stollberg and Berg, 1987) as well as in developing model has been supported by a number of studies showing an chick and rat muscle (Devreotes et al., 1978;  Merlie and Lindagonist-induced conversion of muscle and electric organ AChRs Strom, 1983; Merlie, 1984; Pestronk, 1985) . The reduced proto a desensitized form having increased affinity for agonist and portion of intracellular receptors in adrenal chromaffin cells may no change in affinity for antagonists (Rang and Ritter, 1969, reflect the fact that the cells were obtained from adult tissue and 1970a, b; Sine and Taylor, 1979; Weiland and Taylor, 1979;  have lost an embryonic feature. Embryonic rat brain contains Heidmann et al., 1983) . Similar explanations are likely to hold a large intracellular pool of voltage-dependent sodium channel for differences observed in agonist affinity measured by receptor protein, which is much reduced in adult tissue (Schmidt et al., activation and that measured by competition with labeled re-1985) and the intracellular pool of AChR in muscle is reduced ceptor ligands for binding to AChRs both in the central and in adult rats (Pestronk, 1985) . Precedence for an altered ratio peripheral nervous systems (Halvorsen and Berg, 1986 ; Whiting of binding sites on intracellular receptor comes from studies on and Lindstrom, 1986b) . muscle AChR intracellular precursors, which acquire binding Substance P was used in the present studies to enhance the sites for d-tubocurarine and cu-Bgt at different times during rerate of agonist-induced AChR desensitization and provided eviceptor maturation (Carlin et al., 1986) . dence that desensitization is the rate-limiting step in jH-nicotine
No evidence for heterogeneity of adrenal chromaffin AChRs binding. Substance P only exerts its modulatory action in the was obtained from the equilibrium binding studies, kinetic analpresence of agonist since prior exposure to substance P alone yses, or physiological assays of classical agonist and antagonist has no effect on receptor function. Enhancement of agonistinteractions with the receptor. The complete removal of highinduced AChR desensitization by substance P has previously affinity nicotine binding sites from the surface of the cells by been reported for bovine chromaffin cells (Clapham and Neher, mAb 35 treatment also supports this interpretation. n-Bgt 1984) and also for the rat pheocromocytoma cell line PC1 2 competition with 'H-nicotine for binding, however, occurs over (Stallcup and Patrick, 1980) . In contrast, Livett and coworkers a broad range of toxin concentrations and suggests heterogeneity reported that, although substance P inhibits agonist-induced in the interactions of the toxin with the receptor. A similar broad catecholamine release from chromaffin cells (Mizobe et al., 1979;  concentration dependence was previously observed for blockade Livett and Boska, 1984) it protects against receptor desensitiof receptor function by n-Bgt (Higgins and Berg, 1987a) . The zation produced by prior exposure to agonist. This differs from apparent heterogeneity does not reflect a contribution from a-Bgt our results and may be a consequence of the relatively high binding sites on the cells. Though 2 separate classes of highconcentrations of ACh (> 1 O-4 M) and nicotine (> 2.5 x 1 O-6 M) affinity 3H-nicotine binding sites were detected, one representing used in the preincubations in their protocols compared with the the AChR and the other representing the a-Bgt binding comlow concentrations of nicotine (< 1 Om7 M) used here.
ponent, high concentrations of a-Bgt were consistently used to The stoichiometry of about 1: 1 for mAb 35 and nicotine block the latter. This approach was adopted because previous binding sites on bovine adrenal chromaffin cells suggests simstudies (Trifaro and Lee, 1980; Kilpatrick et al., 198 l) , as well ilarities between the adrenal chromaffin AChR and AChRs from as those described here with mAb-mediated modulation, inmuscle and electric organ. In the latter cases, the receptors are dicated that the oc-Bgt binding component is distinct from the known to contain 2 (Y subunits, each having an agonist binding AChR on the cells. The molecular basis for the apparent hetsite and a mAb 35 binding site (McCarthy et al., 1986) . Imerogeneity of n-Bgt binding to the AChR is unknown. munoaffinity-purified AChRs from chicken brain (Whiting and The demonstration that desensitized adrenal chromaffin Lindstrom, 1986a) and from bovine adrenal medulla (S. Swope AChRs bind agonist with greater affinity resolves discrepancies and D. Berg, unpublished observations) appear to have at least between agonist affinities inferred from equilibrium binding 2 mAb 35 binding sites per receptor, since immobilization of studies and those inferred from receptor activation. To the exreceptor by mAb 35 coupled to Sepharose still permits the detent that adrenal chromaffin AChRs are representative of neutection of additional mAb 35 binding sites on the receptors. ronal receptors, the findings provide further evidence for the Chick ciliary ganglion AChRs display Hill coefficients of about similarity between neuronal and muscle AChRs with respect to 2 for activation by agonists (Brenner and Martin, 1976; Mar- allosteric properties (Changeux et al., 1984) . Both types of regiotta et al., 1987) as do muscle AChRs (Hartzell et al., 1975;  ceptors require at least 2 molecules of agonist for activation, Dionne et al., 1978) . Subunit analyses of neuronal and adrenal both are desensitized by exposure to agonist, both desensitize medullary AChRs, however, suggest substantial differences from that of muscle AChRs Lindstrom, 1986a, 1987a, b; Halvorsen and Berg, 1987; S. Swope and D. Berg, unpublished observations) . The mAb 35 and nicotine binding sites may even be associated with separate subunits in neuronal AChRs (Halvorsen and Berg, 1987; Whiting and Lindstrom, 1987a, b) .
The ratio of mAb 35 and nicotine binding is approximately 1 both for surface sites and for total sites in adrenal chromaffin culture membranes. In principle, one could calculate the ratio for internal sites, as well, by subtracting surface sites from total sites to obtain intracellular AChRs sites for each ligand. In the present case, the relatively large errors associated with calculated values for numbers of internal sites prevents a ratio from being determined. About 20% of the total AChRs associated with the adrenal chromaffin cells are intracellular. This contrasts with the large proportion of intracellular AChRs present in embrymore rapidly in the presence of substance P, and both display increased agonist affinity when desensitized. The allosteric similarities are impressive in view of the likely differences in structure between neuronal and muscle AChRs (Boulter et al., 1986; Lindstrom, 1986a, 1987a, b) .
